ARCHIVES

FDA IND Approval Of New Cancer Drug Is First Based On Phase 1 Clinical Trials In Europe

This article is from The Cancer Letter archive.

Vol. 12 No. 47 | December 5, 1986

Download PDF Visit The Full Archive

Related Articles

DCT Advisors Reject MRS Concept, Approve RDOG Expansion

November 30, 1990

Two former Bristol-Myers Squibb executives were indicted as the company agreed to pay $300 million to investors.

June 17, 2005

Bach: LCA Center Certification Untrustworthy; CISNET Models Don’t Match

May 9, 2014

LAK/IL-2 Extramural Trials Expanded to 20 More cancers

January 8, 1988

NRC considering “Escalated” Enforcement Action Against NIH

February 2, 1996

OMB Cut $150 Million From NCI Request

March 22, 1974